Sort
15,273 grants matching “antimicrobial resistance”
The role of the tuft cell inflammasome in infection
$394,033Isabella Rauch · Oregon Health & Science University · R01 · FY2022 · AI
Virulence Typing of Pseudomonas Clinical Isolates
$394,012Barbara I Kazmierczak · L2 Diagnostics, Llc · R42 · FY2006 · AI
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
$394,000Scott E. Evans · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · HL
A Meningococcal LOS Vaccine
$394,000John McLeod Griffiss · Northern California Institute/Res/Edu · R01 · FY2007 · AI
Combatting Antimicrobial Resistance
$393,958Elizabeth Lynn Zechiedrich · Baylor College Of Medicine · R56 · FY2014 · AI
Assigning function of unknown genes of Acinetobacter baumanii by cell envelope
$393,888Samuel I. Miller · University Of Washington · U19 · FY2014 · AI
Drug-eluting joint implants with synergistic antimicrobial release and risk stratified models of preclinical efficacy testing
$393,759Ebru Oral · Massachusetts General Hospital · R01 · FY2020 · AR
Chaperone-Assisted Pili Assembly in Pathogenic E. Coli
$393,750Scott J Hultgren · Washington University · R01 · FY2022 · AI
Chaperone-Assisted Pili Assembly in Pathogenic E. Coli
$393,750Scott J Hultgren · Washington University · R01 · FY2023 · AI
Chaperone-Assisted Pili Assembly in Pathogenic E. Coli
$393,750Scott J Hultgren · Washington University · R01 · FY2021 · AI
REGULATION OF HOST RESPONSES TO RESPIRATORY VIRAL INFECTION BY ISG15
$393,750Deborah J Lenschow · Washington University · R01 · FY2021 · AI
Chaperone-Assisted Pili Assembly in Pathogenic E. Coli
$393,750Scott J Hultgren · Washington University · R01 · FY2020 · AI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence
$393,726Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2011 · AI
Biogeography of Microbial and Plant-Derived Redox-Active Small Molecules and Combinatorial Effects on Microbial Growth
$393,718Darcy McRose · Massachusetts Institute Of Technology · R35 · FY2025 · GM
REGULATION OF HOST RESPONSES TO RESPIRATORY VIRAL INFECTION BY ISG15
$393,646Deborah J Lenschow · Washington University · R01 · FY2020 · AI
Forecasting Trachoma Control
$393,570Thomas M Lietman · University Of California, San Francisco · R01 · FY2019 · EY
Biogenesis and Function of Streptococcus Pyogenes Cell Wall
$393,530Natalia Korotkova · University Of Kentucky · R01 · FY2021 · AI
Collaborative Cross of the Microbiome and Metabolic Disease
$393,488Federico E Rey · University Of Wisconsin-Madison · R01 · FY2019 · DK
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens
$393,419Pei Zhou · Duke University · R56 · FY2018 · AI
Project 1
$393,329Beth Fuchs · Miriam Hospital · P20 · FY2019 · GM
Allosteric therapy of the Clostridium difficile toxins
$393,250Tor C. Savidge · Baylor College Of Medicine · R01 · FY2016 · AI
Allosteric therapy of the Clostridium difficile toxins
$393,250Tor C. Savidge · Baylor College Of Medicine · R01 · FY2015 · AI
Allosteric therapy of the Clostridium difficile toxins
$393,250Tor C. Savidge · Baylor College Of Medicine · R01 · FY2014 · AI
Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections
$393,246Vincent M. Rotello · University Of Massachusetts Amherst · R01 · FY2022 · AI
Analysis of interacellular host defenses in Salmonella pathogenesis
$393,233Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2011 · AI